Cargando…
Endoscopic debulking resection with additive chemoradiotherapy: Optimal management of advanced inoperable esophageal squamous cell carcinoma
BACKGROUND: There is no remedial strategy other than definitive chemoradiotherapy for patients with advanced esophageal squamous cell carcinoma (ESCC) who are not eligible to undergo surgical treatment. AIM: To introduce a novel therapy called endoscopic debulking resection (EdR) followed by additiv...
Autores principales: | Ren, Li-Hua, Zhu, Ye, Chen, Rong, Shrestha Sachin, Mulmi, Lu, Qin, Xie, Wei-Hua, Lu, Tong, Wei, Xiao-Ying, Shi, Rui-Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516645/ https://www.ncbi.nlm.nih.gov/pubmed/36187386 http://dx.doi.org/10.4251/wjgo.v14.i9.1758 |
Ejemplares similares
-
SGK3 overexpression correlates with a poor prognosis in endoscopically resected superficial esophageal squamous cell neoplasia: A long-term study
por: Xu, Ning, et al.
Publicado: (2023) -
A phase II study of concurrent chemoradiotherapy and erlotinib for inoperable esophageal squamous cell carcinoma
por: Zhao, Chuanhua, et al.
Publicado: (2016) -
Radiofrequency Ablation for Early Superficial Flat Esophageal Squamous Cell Neoplasia: A Comprehensive Review
por: Lei, Siyu, et al.
Publicado: (2020) -
New magnifying endoscopic classification for superficial esophageal squamous cell carcinoma
por: Kim, Su Jin, et al.
Publicado: (2017) -
Is There a Benefit in Receiving Concurrent Chemoradiotherapy for Elderly Patients with Inoperable Thoracic Esophageal Squamous Cell Carcinoma?
por: Zhang, Peng, et al.
Publicado: (2014)